FLT3 Internal Tandem Duplication Positive
2 clinical trials · Condition
◉ Watch FLT3 Internal Tandem Duplication Positive
| Record | Firm | Date |
|---|---|---|
| Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML (NCT07259707) | First Affiliated Hospital of Zhejiang University | 2026-01-25 |
| Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT01892371) | M.D. Anderson Cancer Center | 2013-11-12 |
Track FLT3 Internal Tandem Duplication Positive automatically
Every clearance here is in the API, with alerts when new ones post.